Blueberry Extract - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The blueberry extract market size was valued at USD 113.15 million in 2025 and estimated to grow from USD 124.39 million in 2026 to reach USD 199.95 million by 2031, at a CAGR of 9.94% during the forecast period (2026-2031). This report is Segmented by Product Type (Liquid, Powder), Application (Food and Beverages, Nutraceuticals and Dietary Supplements, Pharmaceuticals, Cosmetics and Personal Care), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Blueberry Extract Market Trends and Insights

Rising Demand for Natural Antioxidants in Functional Foods and Beverages

Manufacturers of functional yogurt, kombucha, kefir, and ready-to-drink tea are substituting synthetic antioxidants with blueberry anthocyanins to satisfy clean-label mandates and capture premium shelf pricing. A standardized extract delivers DPPH activity of 39.91 mg Trolox equivalents per gram and ABTS activity of 19.01 mg Trolox equivalents per gram, outperforming many botanical alternatives on a per-gram basis. Encapsulating blueberry juice in sodium alginate macrogels preserves total phenolics at 119 - 121 µg gallic acid equivalents per milliliter for 15 days under refrigeration while ABTS inhibition remains near 97%, enabling dairy formulators to maintain antioxidant claims without reformulation. Fermented beverages enriched with anthocyanin extracts modulate gut microbiota by influencing NF-κB and PI3K/AKT signaling, so brands can position products for both taste and wellness. These dual sensory and health benefits are driving the blueberry extract market into premium beverage niches where consumers are willing to pay more for verified functionality.

Rising Applications in Dietary Supplements

Dietary supplements are expected to contribute the largest share. This growth is supported by dose-response evidence from peer-reviewed studies. For example, the Norwegian ACID study found that a daily intake of 320 mg of purified berry anthocyanins enhanced cognitive function in adults with high inflammation over 24 weeks. Commercial products have adopted similar dosage levels. Life Extension, for instance, offers a formulation containing 425 mg of wild blueberry extract and 75 mg of BlueActiv for DNA support, priced at USD 17.25 for a 60-count bottle. Furthermore, combination capsules that include blueberry extract with 30% punicalagin and pomegranate extract are available at USD 22.50, targeting cardiovascular health through complementary polyphenols. The demand for gummy and liquid formats, which require soluble extracts for consistent dispersion, is also rising. This trend is fueling the growth of liquid products, which currently show the fastest CAGR in the blueberry extract market.

Fluctuating Raw Material Prices Due to Seasonal Blueberry Supply Variability

Blueberry supply chains are heavily affected by seasonal and climatic volatility, disrupting pricing stability and margin predictability. In 2024, Michigan growers reported production costs surpassing USD 10,000 per acre, with harvest and packing comprising 56% of these costs and labor accounting for 42%, leaving margins highly vulnerable to yield variations. Frost damage in Ukraine during 2024 led to a 39% drop in blueberry prices compared to the six-year average, rendering small farms unprofitable and reducing pomace availability for extract processors. Conversely, Georgia's 2025 outlook forecasts stronger prices due to crop damage from Hurricane Helene, resulting in regional price disparities that complicate long-term supply agreements. Peru's export volume rose by 24% year-over-year, reaching USD 1.68 billion in 2023, while Mexico's 2024 harvest declined due to drought and sanitary issues, underscoring the risks of single-origin dependencies. Extract manufacturers without vertically integrated pomace sourcing or diversified procurement strategies face margin pressures when spot prices increase, limiting their ability to fulfill fixed-price contracts with pharmaceutical and cosmetic clients who require cost stability.

Other drivers and restraints analyzed in the detailed report include:

• Clean-Label and Super-Fruit Positioning in Cosmetics and Skin-Care Products
• Advancements in Extraction Technologies
• Stringent Regulatory Compliance for Quality, Safety, and Health Claims

Segment Analysis

Powder formulations held 46.24% of the 2025 market share, reflecting their dominance in capsule and tablet supplements, where shelf stability and dosing precision matter most. Spray-drying with maltodextrin retains up to 98% of anthocyanins and produces free-flowing powders with moisture content below 5%, meeting pharmaceutical excipient standards for encapsulation. Yet liquid extracts are forecast to grow at 11.29% CAGR through 2031, driven by beverage and cosmetic applications where solubility and rapid absorption are critical. Shenyang Agricultural University's patented high-stability liquid anthocyanin process, commercialized by Zhejiang Lanmei Technology in 2024, addresses the historical instability of liquid formats by maintaining anthocyanin integrity under ambient storage, enabling ready-to-drink formulators to avoid refrigeration costs. Encapsulation with beta-casein and carboxymethylcellulose increases liquid extract bioavailability tenfold, creating a technical moat for suppliers who license or develop similar formulations.

Powder extracts benefit from lower freight costs and longer shelf life, making them the preferred format for export-oriented Chinese suppliers who serve price-sensitive supplement brands. Chinese manufacturers quote USD 10 to USD 334 per kilogram for powder extracts, depending on anthocyanin concentration, with standardized 25% anthocyanin powders commanding mid-range pricing. Liquid extracts, by contrast, require cold-chain logistics and have shorter shelf lives unless stabilized through encapsulation or co-pigmentation, raising landed costs by 15 to 20%. However, cosmetic formulators accept this premium because liquid extracts disperse uniformly in emulsions and serums without the grittiness that can occur with powder suspensions.

Complete Report Scope:

• By Product Type
  • Liquid
  • Powder
• By Application
  • Food and Beverages
  • Nutraceuticals and Dietary Supplements
  • Pharmaceuticals
  • Cosmetics and Personal Care
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Geography Analysis

North America held 37.84% of the 2025 market share, supported by FDA GRAS recognition for berry anthocyanins and well-established distribution networks through GNC, Whole Foods, and specialty supplement retailers. FutureCeuticals' collaboration with Global Calcium in November 2024 expanded its presence into Asia, the Middle East, and Africa, reflecting the recognition of growth limitations within the North American market. The FDA's December 2024 revision to the "healthy" claim definition allows berry-fortified foods with added sugars, provided they adhere to specified limits. This regulatory change creates new opportunities for functional snacks and beverages that were previously restricted. However, Michigan's production costs, exceeding USD 10,000 per acre, with labor accounting for 42% of these costs, are prompting extract manufacturers to source pomace from lower-cost regions such as Chile and Peru. FutureCeuticals' acquisition of SouthAm Freeze Dry in May 2025 secures supply at the source, showcasing a trend toward vertical integration. This shift indicates that North American extract suppliers are increasingly adopting global procurement strategies to reduce risks associated with regional weather conditions and labor shortages.

The Asia-Pacific region is expected to grow at a CAGR of 12.31% through 2031, the fastest rate among all geographies. This growth is driven by China's annual berry harvest of 3.3 million tonnes and regulatory frameworks that ease market entry for functional foods. Shenyang Agricultural University's microencapsulation technology, approved by China's National Health Commission and commercialized by Zhejiang Lanmei Technology in 2024, illustrates how domestic R&D is reducing dependence on Western extraction platforms. In Japan, the Foods with Function Claims system enables anthocyanin products to enter the market through notification after submitting clinical trials or systematic reviews, bypassing the lengthy and costly FOSHU approval process that traditionally favored large pharmaceutical companies.

Europe faces regulatory challenges as the European Food Safety Authority (EFSA) has not approved specific health claims for anthocyanins, limiting label differentiation and forcing brands to rely on generic antioxidant messaging. While the European Union's ban on 1,328 cosmetic substances has driven demand for natural alternatives, the absence of approved health claims for oral supplements restricts market growth compared to North America and the Asia-Pacific. According to Rabobank's 2024 update, the European blueberry supply remains constrained, with high prices encouraging extract manufacturers to import pomace from regions like Peru and Mexico. In 2024, Mexico alone produced 81,000 metric tonnes of blueberries. South America, led by Peru's USD 1.68 billion in blueberry exports in 2023, is becoming a key raw-material hub. FutureCeuticals' acquisition of SouthAm Freeze Dry positions the company to secure pomace at processing sites, gaining a competitive edge over rivals. The Middle East and Africa are still developing markets for berry anthocyanins. However, FutureCeuticals' distribution partnership with Global Calcium indicates the early establishment of distribution channels in these regions, suggesting potential for future growth.

List of Companies Covered in this Report:

• FutureCeuticals
• Berrico FoodCompany BV
• Nutra Green Biotechnology Co., Ltd.
• Shaanxi Guanjie Bio-technology Co. Ltd.
• JF Natural
• Bio-Botanica Inc.
• Mazza Innovation Ltd.
• Life Extension
• Carrubba Inc.
• Herbo Nutra
• Naturalin Bio-Resources Co., Ltd.
• Swanson Health Products
• Nature’s Way Products LLC
• Givaudan (Naturex)
• Sensient Technologies
• Döhler Group
• Ingredion Incorporated
• Symrise AG
• Hunan Nutramax Inc.
• Xi’an Greena Biotech

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support